Predicting analysis times in randomized clinical trials with cancer immunotherapy
Crossref DOI link: https://doi.org/10.1186/s12874-016-0117-3
Published Online: 2016-02-01
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Tai-Tsang
Funding for this research was provided by:
Bristol-Myers Squibb (US)
